Evidence map›Paper›PMID 30638443›Full record

ArticleeLife2019

The

Cassandra Kamischke, Junping Fan, Julien Bergeron, Hemantha D Kulasekara, Zachary D Dalebroux, Anika Burrell, Justin M Kollman, Samuel I Miller

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Mla system and its role in maintaining outer membrane barrier function inFrontiers in cellular and infection microbiology · 2024
    Article
  14. Article
  15. Insights into the Mechanisms of Reuterin againstFoods (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Review
  18. A periplasmic phospholipase that maintains outer membrane lipid asymmetry inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Cassandra KamischkeDepartment of Microbiology, University of Washington, Seattle, United States.
Junping FanDepartment of Microbiology, University of Washington, Seattle, United States.
Julien BergeronDepartment of Biochemistry, University of Washington, Seattle, United States.
Hemantha D KulasekaraDepartment of Microbiology, University of Washington, Seattle, United States.
Zachary D DalebrouxDepartment of Microbiology, University of Washington, Seattle, United States.
Anika BurrellDepartment of Biochemistry, University of Washington, Seattle, United States.
Justin M KollmanDepartment of Biochemistry, University of Washington, Seattle, United States.
Samuel I MillerDepartment of Microbiology, University of Washington, Seattle, United States.ORCID 0000-0003-1638-2181
University of Washington · US

Funding

TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
Protein Interaction Technology CoreU19AI107775 · NIAID · UNIVERSITY OF WASHINGTON · PI BRITTNACHER, MITCHELL J · 2013 to 2017
$7.7M
The Structure and Function of Metabolic FilamentsR01GM118396 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M · 2016 to 2023
$2.9M
NIAID NIH HHS U19 AI107775NIGMS NIH HHS R01 GM118396NIGMS NIH HHS T32 GM008268NIH HHS R01GM118396
6 · The paper itself

Abstract

The outer membrane (OM) of Gram-negative bacteria serves as a selective permeability barrier that allows entry of essential nutrients while excluding toxic compounds, including antibiotics. The OM is asymmetric and contains an outer leaflet of lipopolysaccharides (LPS) or lipooligosaccharides (LOS) and an inner leaflet of glycerophospholipids (GPL). We screened

Indexed as

Acinetobacter baumanniiAdenosine TriphosphateAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBiological TransportCell MembraneComputational BiologyCryoelectron MicroscopyDNA Transposable ElementsEscherichia coliEscherichia coli ProteinsGenome, BacterialGlycerophospholipidsHydrolysisLipopolysaccharidesMolecular ConformationAdenosine TriphosphateAnti-Bacterial AgentsBacterial Outer Membrane ProteinsDNA Transposable ElementsEscherichia coli ProteinsGlycerophospholipidslipid-linked oligosaccharidesLipopolysaccharidesABC TransporterAcinetobacter baumanniiglycerophospholipidsinfectious diseasemicrobiology

Identifiers

PMID30638443
PMCPMC6365058
OpenAlexW2886883917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.